We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VIA:NYSEVia Transportation, Inc. Analysis

Data as of 2026-09-01 - not real-time

$27.50

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Via Transportation, Inc. is priced at $27.50 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 52.1%. With RSI at 68.2 the momentum picture is approaching overbought, alongside a bearish MACD signal. The recent range runs from support at $20.10 up to resistance at $29.11.
Valuation screens as fair: a P/E of 64.0 sits above the sector average of 35.3. Sell-side targets cluster 23.6% above the current quote. Revenue is growing at 26.7% on a -20.0% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 51.7%, a beta of 1.13 and a maximum drawdown of 75.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Via Transportation, Inc. VIA Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire...Via Transportation, Inc. VIA Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire...VIA Deadline Alert: Levi & Korsinsky Reminds Via Transportation, Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 21.35
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 64.0 versus sector average of 35.3
  • Trading above the 200-day average of 21.35

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 64.0 versus sector average of 35.3
  • Negative profit margin of -20.0%
  • Analyst targets imply +23.6% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth26.70%
Profit Margin-20.04%
P/E Ratio64.0
ROE-23.61%
ROA-9.92%
Debt/Equity2.92
P/B Ratio3.6
Op. Cash Flow$-40827000
Free Cash Flow$-22626624
Industry P/E35.3

Technical Analysis

TrendBullish
RSI68.2
Support$20.10
Resistance$29.11
MA 20$25.82
MA 50$21.43
MA 200$21.35
MACDBearish
VolumeDecreasing
Fear & Greed Index92.25

Valuation

Target Price$34.00
Upside/Downside23.64%
GradeFair
TypeGrowth

Risk Assessment

Beta1.13
Volatility51.73%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.